Literature DB >> 32871837

A Case Series of BCOR Sarcomas With a New Splice Variant of BCOR/CCNB3 Fusion Gene.

Anastasios Kyriazoglou1, Natalia Tourkantoni2, Michalis Liontos3, Flora Zagouri3, Louisa Mahaira4, Alexandra Papakosta4, Dimitra Michali4, Amalia Patereli5, Kalliopi Stefanaki5, Vasiliki Tzotzola6, Evangelia Skoura7, Margarita Baka8, Sofia Polychronopoulou6, Antonis Kattamis2, Efthymios Dimitriadis4.   

Abstract

BACKGROUND/AIM: Undifferentiated round cell sarcomas are a heterogeneous group of sarcomas. Identification of BCOR alterations, such as BCOR/CCNB3 and BCOR/MAML3 fusion genes and BCOR ITD has recently contributed in the precise diagnosis of these neoplasms, defining a new entity of the current classification of soft tissue and bone sarcomas. BCOR sarcomas share both morphological and genetic characteristics distinct from Ewing sarcomas. The scope of our study was to retrospectively identify BCOR sarcomas and find the correlations with the clinical outcome of these patients. PATIENTS AND METHODS: Histopathology and immunohistochemistry of pediatric tumor samples were combined with molecular testing (PCR) and fluorescent in situ hybridization to find BCOR sarcomas.
RESULTS: We, herein, present our experience with BCOR sarcomas in a referral center of Greece. Moreover, we report in one case the detection of a variant BCOR/CCNB3 fusion not previously described.
CONCLUSION: We are the first to report a splice variant of BCOR/CCNB3 which reveals the central position of BCOR in the oncogenesis of these tumors, furthermore we highlight the importance of molecular diagnostics in Ewing-like sarcomas and discuss the current treatment options for this rare entity. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  BCOR; chemotherapy; ewing-like sarcomas; fusion gene

Mesh:

Substances:

Year:  2020        PMID: 32871837      PMCID: PMC7652470          DOI: 10.21873/invivo.12125

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  33 in total

1.  Novel BCOR-MAML3 and ZC3H7B-BCOR Gene Fusions in Undifferentiated Small Blue Round Cell Sarcomas.

Authors:  Katja Specht; Lei Zhang; Yun-Shao Sung; Marisa Nucci; Sarah Dry; Sumathi Vaiyapuri; Gunther H S Richter; Christopher D M Fletcher; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2016-04       Impact factor: 6.394

2.  Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  P G Casali; S Bielack; N Abecassis; H T Aro; S Bauer; R Biagini; S Bonvalot; I Boukovinas; J V M G Bovee; B Brennan; T Brodowicz; J M Broto; L Brugières; A Buonadonna; E De Álava; A P Dei Tos; X G Del Muro; P Dileo; C Dhooge; M Eriksson; F Fagioli; A Fedenko; V Ferraresi; A Ferrari; S Ferrari; A M Frezza; N Gaspar; S Gasperoni; H Gelderblom; T Gil; G Grignani; A Gronchi; R L Haas; B Hassan; S Hecker-Nolting; P Hohenberger; R Issels; H Joensuu; R L Jones; I Judson; P Jutte; S Kaal; L Kager; B Kasper; K Kopeckova; D A Krákorová; R Ladenstein; A Le Cesne; I Lugowska; O Merimsky; M Montemurro; B Morland; M A Pantaleo; R Piana; P Picci; S Piperno-Neumann; A L Pousa; P Reichardt; M H Robinson; P Rutkowski; A A Safwat; P Schöffski; S Sleijfer; S Stacchiotti; S J Strauss; K Sundby Hall; M Unk; F Van Coevorden; W T A van der Graaf; J Whelan; E Wardelmann; O Zaikova; J Y Blay
Journal:  Ann Oncol       Date:  2018-10-01       Impact factor: 32.976

3.  BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.

Authors:  Adrián Mariño-Enriquez; Alexandra Lauria; Joanna Przybyl; Tony L Ng; Magdalena Kowalewska; Maria Debiec-Rychter; Raji Ganesan; Vaiyapuri Sumathi; Suzanne George; W Glenn McCluggage; Marisa R Nucci; Cheng-Han Lee; Jonathan A Fletcher
Journal:  Am J Surg Pathol       Date:  2018-03       Impact factor: 6.394

4.  BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.

Authors:  Sarah Chiang; Cheng-Han Lee; Colin J R Stewart; Esther Oliva; Lien N Hoang; Rola H Ali; Martee L Hensley; Javier A Arias-Stella; Denise Frosina; Achim A Jungbluth; Ryma Benayed; Marc Ladanyi; Meera Hameed; Lu Wang; Yu-Chien Kao; Cristina R Antonescu; Robert A Soslow
Journal:  Mod Pathol       Date:  2017-06-16       Impact factor: 7.842

5.  Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis.

Authors:  Kazuki Terada; Hiroki Yamaguchi; Toshimitsu Ueki; Kensuke Usuki; Yutaka Kobayashi; Kenji Tajika; Seiji Gomi; Saiko Kurosawa; Riho Saito; Yutaka Furuta; Keiki Miyadera; Taichiro Tokura; Atsushi Marumo; Ikuko Omori; Masahiro Sakaguchi; Yusuke Fujiwara; Shunsuke Yui; Takeshi Ryotokuji; Kunihito Arai; Tomoaki Kitano; Satoshi Wakita; Takahiro Fukuda; Koiti Inokuchi
Journal:  Genes Chromosomes Cancer       Date:  2018-08       Impact factor: 5.006

6.  Recurrent BCOR internal tandem duplication and BCOR or BCL6 expression distinguish primitive myxoid mesenchymal tumor of infancy from congenital infantile fibrosarcoma.

Authors:  Teresa Santiago; Michael R Clay; Sariah J Allen; Brent A Orr
Journal:  Mod Pathol       Date:  2017-03-03       Impact factor: 7.842

7.  Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial.

Authors:  Antoine Italiano; Olivier Mir; Simone Mathoulin-Pelissier; Nicolas Penel; Sophie Piperno-Neumann; Emmanuelle Bompas; Christine Chevreau; Florence Duffaud; Natacha Entz-Werlé; Esma Saada; Isabelle Ray-Coquard; Cyril Lervat; Nathalie Gaspar; Perrine Marec-Berard; Hélène Pacquement; John Wright; Maud Toulmonde; Alban Bessede; Amandine Crombe; Michèle Kind; Carine Bellera; Jean-Yves Blay
Journal:  Lancet Oncol       Date:  2020-02-17       Impact factor: 41.316

8.  Structure of the polycomb group protein PCGF1 in complex with BCOR reveals basis for binding selectivity of PCGF homologs.

Authors:  Sarah E Junco; Renjing Wang; John C Gaipa; Alexander B Taylor; Virgil Schirf; Micah D Gearhart; Vivian J Bardwell; Borries Demeler; P John Hart; Chongwoo A Kim
Journal:  Structure       Date:  2013-03-21       Impact factor: 5.006

9.  Whole transcriptome sequencing identifies BCOR internal tandem duplication as a common feature of clear cell sarcoma of the kidney.

Authors:  Annalisa Astolfi; Fraia Melchionda; Daniela Perotti; Maura Fois; Valentina Indio; Milena Urbini; Chiara Giusy Genovese; Paola Collini; Nunzio Salfi; Marilina Nantron; Paolo D'Angelo; Filippo Spreafico; Andrea Pession
Journal:  Oncotarget       Date:  2015-12-01

10.  Recurrent internal tandem duplications of BCOR in clear cell sarcoma of the kidney.

Authors:  Angshumoy Roy; Vijetha Kumar; Barry Zorman; Erica Fang; Katherine M Haines; HarshaVardhan Doddapaneni; Oliver A Hampton; Simon White; Abhishek A Bavle; Nimesh R Patel; Karen W Eldin; M John Hicks; Dinesh Rakheja; Patrick J Leavey; Stephen X Skapek; James F Amatruda; Jed G Nuchtern; Murali M Chintagumpala; David A Wheeler; Sharon E Plon; Pavel Sumazin; D Williams Parsons
Journal:  Nat Commun       Date:  2015-11-17       Impact factor: 14.919

View more
  1 in total

Review 1.  Small round cell sarcomas.

Authors:  Florencia Cidre-Aranaz; Sarah Watson; James F Amatruda; Takuro Nakamura; Olivier Delattre; Enrique de Alava; Uta Dirksen; Thomas G P Grünewald
Journal:  Nat Rev Dis Primers       Date:  2022-10-06       Impact factor: 65.038

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.